Cite
Thomson KS, Odom GL, Murry CE, et al. Translation of Cardiac Myosin Activation with 2-deoxy-ATP to Treat Heart Failure via an Experimental Ribonucleotide Reductase-Based Gene Therapy. JACC Basic Transl Sci. 2016;1(7):666-679doi: 10.1016/j.jacbts.2016.07.006.
Thomson, K. S., Odom, G. L., Murry, C. E., Mahairas, G. G., Moussavi-Harami, F., Teichman, S. L., Chen, X., Hauschka, S. D., Chamberlain, J. S., & Regnier, M. (2016). Translation of Cardiac Myosin Activation with 2-deoxy-ATP to Treat Heart Failure via an Experimental Ribonucleotide Reductase-Based Gene Therapy. JACC. Basic to translational science, 1(7), 666-679. https://doi.org/10.1016/j.jacbts.2016.07.006
Thomson, Kassandra S, et al. "Translation of Cardiac Myosin Activation with 2-deoxy-ATP to Treat Heart Failure via an Experimental Ribonucleotide Reductase-Based Gene Therapy." JACC. Basic to translational science vol. 1,7 (2016): 666-679. doi: https://doi.org/10.1016/j.jacbts.2016.07.006
Thomson KS, Odom GL, Murry CE, Mahairas GG, Moussavi-Harami F, Teichman SL, Chen X, Hauschka SD, Chamberlain JS, Regnier M. Translation of Cardiac Myosin Activation with 2-deoxy-ATP to Treat Heart Failure via an Experimental Ribonucleotide Reductase-Based Gene Therapy. JACC Basic Transl Sci. 2016 Dec;1(7):666-679. doi: 10.1016/j.jacbts.2016.07.006. PMID: 28553667; PMCID: PMC5444879.
Copy
Download .nbib